Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:
The Company's issued share capital as at 30 September 2022 consisted of 4,311,302,410 shares of 31 ¼ pence each ('Ordinary Shares'), of which 243,924,760 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is 4,067,377,650. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Notifications may be sent to firstname.lastname@example.org.
V A Whyte
3 October 2022